Moreover, several studies support that ANXA1 is frequently linked to advanced stage, aggressive tumor behavior, and poor outcome, being consequently regarded as an independent prognostic marker of a patient’s survival [17,24]. This evidence concerns the gene ANXA1 and neoplasm.